Antibody-mediated rejection criteria - An addition to the Banff '97 classification of renal allograft rejection

Lorraine C. Racusen; Robert B. Colvin; Kim Solez; Michael J. Mihatsch; Philip F. Halloran; Patricia M. Campbell; Michael J. Cecka; Jean Pierre Cosyns; Anthony J. Demetris; Michael C. Fishbein; Agnes Fogo; Peter Furness; Ian W. Gibson; Denis Glotz; Pekka Hayry; Lawrence Hunsickern; Michael Kashgarian; Ronald Kerman; Alex J. Magil; Robert Avery Montgomery; Kunio Morozumi; Volker Nickeleit; Parmjeet Randhawa; Heinz Regele; Daniel Seron; Surya Seshan; Stale Sund; Kiril Trpkov

doi:10.1034/j.1600-6143.2003.00072.x

Antibody-mediated rejection criteria - An addition to the Banff '97 classification of renal allograft rejection

Lorraine C. Racusen, Robert B. Colvin, Kim Solez, Michael J. Mihatsch, Philip F. Halloran, Patricia M. Campbell, Michael J. Cecka, Jean Pierre Cosyns, Anthony J. Demetris, Michael C. Fishbein, Agnes Fogo, Peter Furness, Ian W. Gibson, Denis Glotz, Pekka Hayry, Lawrence Hunsickern, Michael Kashgarian, Ronald Kerman, Alex J. Magil, Robert Avery MontgomeryKunio Morozumi, Volker Nickeleit, Parmjeet Randhawa, Heinz Regele, Daniel Seron, Surya Seshan, Stale Sund, Kiril Trpkov

School of Medicine

Research output: Contribution to journal › Article › peer-review

897 Scopus citations

Abstract

Antibody-mediated rejection (AbAR) is increasingly recognized in the renal allograft population, and successful therapeutic regimens have been developed to prevent and treat AbAR, enabling excellent outcomes even in patients highly sensitized to the donor prior to transplant. It has become critical to develop standardized criteria for the pathological diagnosis of AbAR. This article presents international consensus criteria for and classification of AbAR developed based on discussions held at the Sixth Banff Conference on Allograft Pathology in 2001. This classification represents a working formulation, to be revisited as additional data accumulate in this important area of renal transplantation.

Original language	English (US)
Pages (from-to)	708-714
Number of pages	7
Journal	American Journal of Transplantation
Volume	3
Issue number	6
DOIs	https://doi.org/10.1034/j.1600-6143.2003.00072.x
State	Published - Jun 2003

Keywords

Antibody
Banff
Pathology
Rejection

ASJC Scopus subject areas

Immunology and Allergy
Transplantation
Pharmacology (medical)

Access to Document

10.1034/j.1600-6143.2003.00072.x

Cite this

Racusen, L. C., Colvin, R. B., Solez, K., Mihatsch, M. J., Halloran, P. F., Campbell, P. M., Cecka, M. J., Cosyns, J. P., Demetris, A. J., Fishbein, M. C., Fogo, A., Furness, P., Gibson, I. W., Glotz, D., Hayry, P., Hunsickern, L., Kashgarian, M., Kerman, R., Magil, A. J., ... Trpkov, K. (2003). Antibody-mediated rejection criteria - An addition to the Banff '97 classification of renal allograft rejection. American Journal of Transplantation, 3(6), 708-714. https://doi.org/10.1034/j.1600-6143.2003.00072.x

Racusen, LC, Colvin, RB, Solez, K, Mihatsch, MJ, Halloran, PF, Campbell, PM, Cecka, MJ, Cosyns, JP, Demetris, AJ, Fishbein, MC, Fogo, A, Furness, P, Gibson, IW, Glotz, D, Hayry, P, Hunsickern, L, Kashgarian, M, Kerman, R, Magil, AJ, Montgomery, RA, Morozumi, K, Nickeleit, V, Randhawa, P, Regele, H, Seron, D, Seshan, S, Sund, S & Trpkov, K 2003, 'Antibody-mediated rejection criteria - An addition to the Banff '97 classification of renal allograft rejection', American Journal of Transplantation, vol. 3, no. 6, pp. 708-714. https://doi.org/10.1034/j.1600-6143.2003.00072.x

@article{7a25f5e39c87413aabe4b4f0c8670d54,

title = "Antibody-mediated rejection criteria - An addition to the Banff '97 classification of renal allograft rejection",

abstract = "Antibody-mediated rejection (AbAR) is increasingly recognized in the renal allograft population, and successful therapeutic regimens have been developed to prevent and treat AbAR, enabling excellent outcomes even in patients highly sensitized to the donor prior to transplant. It has become critical to develop standardized criteria for the pathological diagnosis of AbAR. This article presents international consensus criteria for and classification of AbAR developed based on discussions held at the Sixth Banff Conference on Allograft Pathology in 2001. This classification represents a working formulation, to be revisited as additional data accumulate in this important area of renal transplantation.",

keywords = "Antibody, Banff, Pathology, Rejection",

author = "Racusen, {Lorraine C.} and Colvin, {Robert B.} and Kim Solez and Mihatsch, {Michael J.} and Halloran, {Philip F.} and Campbell, {Patricia M.} and Cecka, {Michael J.} and Cosyns, {Jean Pierre} and Demetris, {Anthony J.} and Fishbein, {Michael C.} and Agnes Fogo and Peter Furness and Gibson, {Ian W.} and Denis Glotz and Pekka Hayry and Lawrence Hunsickern and Michael Kashgarian and Ronald Kerman and Magil, {Alex J.} and Montgomery, {Robert Avery} and Kunio Morozumi and Volker Nickeleit and Parmjeet Randhawa and Heinz Regele and Daniel Seron and Surya Seshan and Stale Sund and Kiril Trpkov",

year = "2003",

month = jun,

doi = "10.1034/j.1600-6143.2003.00072.x",

language = "English (US)",

volume = "3",

pages = "708--714",

journal = "American Journal of Transplantation",

issn = "1600-6135",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - Antibody-mediated rejection criteria - An addition to the Banff '97 classification of renal allograft rejection

AU - Racusen, Lorraine C.

AU - Colvin, Robert B.

AU - Solez, Kim

AU - Mihatsch, Michael J.

AU - Halloran, Philip F.

AU - Campbell, Patricia M.

AU - Cecka, Michael J.

AU - Cosyns, Jean Pierre

AU - Demetris, Anthony J.

AU - Fishbein, Michael C.

AU - Fogo, Agnes

AU - Furness, Peter

AU - Gibson, Ian W.

AU - Glotz, Denis

AU - Hayry, Pekka

AU - Hunsickern, Lawrence

AU - Kashgarian, Michael

AU - Kerman, Ronald

AU - Magil, Alex J.

AU - Montgomery, Robert Avery

AU - Morozumi, Kunio

AU - Nickeleit, Volker

AU - Randhawa, Parmjeet

AU - Regele, Heinz

AU - Seron, Daniel

AU - Seshan, Surya

AU - Sund, Stale

AU - Trpkov, Kiril

PY - 2003/6

Y1 - 2003/6

N2 - Antibody-mediated rejection (AbAR) is increasingly recognized in the renal allograft population, and successful therapeutic regimens have been developed to prevent and treat AbAR, enabling excellent outcomes even in patients highly sensitized to the donor prior to transplant. It has become critical to develop standardized criteria for the pathological diagnosis of AbAR. This article presents international consensus criteria for and classification of AbAR developed based on discussions held at the Sixth Banff Conference on Allograft Pathology in 2001. This classification represents a working formulation, to be revisited as additional data accumulate in this important area of renal transplantation.

AB - Antibody-mediated rejection (AbAR) is increasingly recognized in the renal allograft population, and successful therapeutic regimens have been developed to prevent and treat AbAR, enabling excellent outcomes even in patients highly sensitized to the donor prior to transplant. It has become critical to develop standardized criteria for the pathological diagnosis of AbAR. This article presents international consensus criteria for and classification of AbAR developed based on discussions held at the Sixth Banff Conference on Allograft Pathology in 2001. This classification represents a working formulation, to be revisited as additional data accumulate in this important area of renal transplantation.

KW - Antibody

KW - Banff

KW - Pathology

KW - Rejection

UR - http://www.scopus.com/inward/record.url?scp=10744233377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744233377&partnerID=8YFLogxK

U2 - 10.1034/j.1600-6143.2003.00072.x

DO - 10.1034/j.1600-6143.2003.00072.x

M3 - Article

C2 - 12780562

AN - SCOPUS:10744233377

SN - 1600-6135

VL - 3

SP - 708

EP - 714

JO - American Journal of Transplantation

JF - American Journal of Transplantation

IS - 6

ER -

Antibody-mediated rejection criteria - An addition to the Banff '97 classification of renal allograft rejection

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this